Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2690-2692

  Spyridaki, Ioanna ^a,b   Psaroulaki, Anna ^a   Vranakis, Iosif ^a   Tselentis, Yannis ^a   Gikas, Achilleas ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; LINEZOLID; OFLOXACIN; TIGECYCLINE; TROVAFLOXACIN;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COXIELLA BURNETII; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; Q FEVER; VERO CELL;

ANIMALS; ANTI-BACTERIAL AGENTS; CERCOPITHECUS AETHIOPS; COXIELLA BURNETII; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; Q FEVER; VERO CELLS;

EID: 67049145535     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01424-08     Document Type: Article

References (21)

1. Andoh, M., N. Takashi, Y. Tsuyoshi, F. Hideto, and H. Katsuya. 2004. In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii. Microbiol. Immunol. 48:661-664. (Pubitemid 39264938)
2. Craig, W. A. 1995. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn. Microbiol. Infect. Dis. 22:89-96.
3. Edelstein, P. H., W. J. Weiss, and M. A. C. Edelstein. 2003. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia. Antimicrob. Agents Chemother. 47: 533-540.
4. Gikas, A., I. Spyridaki, A. Psaroulaki, D. Kofterithis, and Y. Tselentis. 1998. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob. Agents Chemother. 42:2747-2748.
5. Gikas, A., I. Spyridaki, E. Scoulica, A. Psaroulaki, and Y. Tselentis. 2001. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin. Antimicrob. Agents Chemother. 45:3276-3278.
6. Jabarit-Aldighieri, N., H. Torres, and D. Raoult. 1992. Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:2529-2532.
7. Levy, P. Y., M. Drancourt, J. Etienne, J. C. Auvergnat, J. Beytout, J. M. Sainty, F. Goldstein, and D. Raoult. 1991. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob. Agents Chemother. 35:533-538.
8. Maurin, M., A. M. Benoliel, P. Bongrand, and D. Raoult. 1992. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J. Infect. Dis. 166:1097-1102.
9. Maurin, M., and D. Raoult. 1993. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob. Agents Chemother. 37:2633-2637.
10. Maurin, M., and D. Raoult. 1996. Optimum treatment of intracellular infection. Drugs 52:45-49. (Pubitemid 26193491)
11. Olson, M. W., A. Ruzin, E. Feyfant, T. S. Rush III, J. O'Connell, and P. A. Bradford. 2006. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob. Agents Chemother. 50:2156-2166.
12. Raoult, D. 1991. Antibiotic treatment of rickettsiosis, recent advances and current concepts. Eur. J. Epidemiol. 7:276-281.
13. Raoult, D., H. Torres, and M. Drancourt. 1991. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob. Agents Chemother. 35:2070-2077.
14. Raoult, D. 1993. Treatment of Q fever. Antimicrob. Agents Chemother. 37:1733-1736.
15. Raoult, D., and T. Marrie. 1995. Q fever. Clin. Infect. Dis. 20:489-496.
16. Rolain, J. M., M. Maurin, and D. Raoult. 2001. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Antimicrob. Agents Chemother. 45:301-302.
17. Rolain, J. M., M. N. Mallet, and D. Raoult. 2003. Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis. J. Infect. Dis. 188:1322-1325.
18. Rolain, J. M., A. Boulos, M. N. Mallet, and D. Raoult. 2005. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis. Antimicrob. Agents Chemother. 49:2673-2676.
19. Spyridaki, I., A. Gikas, D. Kofteridis, A. Psaroulaki, and Y. Tselentis. 1998. Q fever in the Greek island of Crete: detection, isolation, and molecular identification of eight strains of Coxiella burnetii from clinical samples. J. Clin. Microbiol. 36:2063-2067.
20. Tselentis, Y., A. Gikas, D. Kofteridis, E. Kyriakakis, N. Lydataki, D. Bouros, and N. Tsaparas. 1995. Q fever in the Greek island of Crete: epidemiological, clinical, and therapeutic data from 98 cases. Clin. Infect. Dis. 20:1311-1316.
21. Yeaman, M. R., L. A. Mitscher, and O. G. Baca. 1987. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob. Agents Chemother. 31:1079-1084.